Jan 3 (Reuters) - Eton Pharmaceuticals Inc ( ETON ):
* ETON PHARMACEUTICALS ADVANCES ITS COMMITMENT TO RARE
DISEASE
WITH THE ACQUISITION OF GALZIN®
* ETON PHARMACEUTICALS INC ( ETON ) - TO COMMERCIALIZE GALZIN IN U.S.
IN Q1
2025
* ETON PHARMACEUTICALS INC ( ETON ): HAS ALSO ACQUIRED EUROPEAN
RIGHTS TO
GALZIN
Source text:
Further company coverage: